Nathan Fountain

Director/Board Member chez ACUMEN PHARMACEUTICALS, INC. Fortune : 25 313 $ au 31/03/2024

Profil

Nathan B.
Fountain is currently the President & Chief Executive Officer at Hexokine Therapeutics, Inc., an Independent Director at Acumen Pharmaceuticals, Inc., and a Professor at The University of Virginia School of Medicine.
He is also the Chairman-Research Roundtable for Epilepsy at the Epilepsy Foundation.
Previously, he served as the President of the National Association of Epilepsy Centers.
Dr. Fountain received his undergraduate degree from the University of Iowa and his doctorate from the University of Iowa Carver College of Medicine.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
ACUMEN PHARMACEUTICALS, INC. 0,01%	06/06/2023	6 250 ( 0,01% )	25 313 $	31/03/2024

Postes actifs de Nathan Fountain

Sociétés	Poste	Début
ACUMEN PHARMACEUTICALS, INC.	Director/Board Member	01/06/2021
Epilepsy Foundation	Corporate Officer/Principal	-
The University of Virginia School of Medicine	Corporate Officer/Principal	-
Hexokine Therapeutics, Inc.	Chief Executive Officer	01/11/2021

Anciens postes connus de Nathan Fountain

Sociétés	Poste	Fin
National Association of Epilepsy Centers	President	-

Formation de Nathan Fountain

University of Iowa	Undergraduate Degree
University of Iowa Carver College of Medicine	Doctorate Degree